FDA and Aetion, a healthcare technology company, are joining forces to study how real-world data can be used to stem the COVID-19 pandemic. The company and FDA will use the Aetion Evidence Platform® to analyze fit-for-purpose data sources to characterize COVID-19 patient populations and their medication use, identify risk factors for COVID-19-related complications, and contribute to research on potential interventions, Aetion announced
Read More
Read More